Cyclacel Pharmaceuticals (CYCCP) News Today → These AI trades triggered this morning (545% return) (From Prosper Trading Academy) (Ad) Free CYCCP Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share HeadlinesStock AnalysisCompetitorsDividendHeadlinesSocial MediaStock AnalysisCompetitorsDividendHeadlinesSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlinemarketbeat.com - April 24 at 2:02 PMmarketbeat.com - April 24 at 1:27 PMmarketbeat.com - April 10 at 1:47 PMCyclacel Pharmaceuticals to Present New Clinical Data at 2024 ASCO Annual Meeting Highlighting Fadraciclib’s Potential as a Precision Medicine for Cancerfinance.yahoo.com - April 1 at 11:33 AMCyclacel Pharmaceuticals to Present New Clinical Data at 2024 ASCO Annual Meeting Highlighting Fadraciclib's Potential as a Precision Medicine for Cancerglobenewswire.com - April 1 at 9:15 AMCyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updateglobenewswire.com - March 19 at 4:05 PMCyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2023 Financial Resultsglobenewswire.com - March 13 at 4:05 PMmarketbeat.com - March 7 at 4:01 PMCyclacel Pharmaceuticals Announces Preclinical Proof-of-Concept Data for Fadraciclib to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2024globenewswire.com - March 7 at 9:15 AMCyclacel Pharmaceuticals Announces Receipt of $2.9 Million R&D Tax Creditglobenewswire.com - March 6 at 9:15 AMCyclacel Pharmaceuticals to Participate in 2024 BIO CEO & Investor Conferencefinance.yahoo.com - February 20 at 10:52 AMCyclacel Pharmaceuticals to Participate in 2024 BIO CEO & Investor Conferenceglobenewswire.com - February 20 at 9:15 AMCyclacel Pharmaceuticals files to sell 411K shares of common stockmsn.com - January 19 at 10:22 PMWhy Is Cyclacel Pharmaceuticals (CYCC) Stock Down 9% Today?investorplace.com - January 9 at 10:03 AMCyclacel Pharmaceuticals announces registered direct and private placement offeringmsn.com - December 22 at 1:11 PMCyclacel Pharmaceuticals Reports Fadraciclib Phase 1 Data Suggesting Efficacy Against Tumors With CDKN2A, CDKN2B and MTAP Deletionsfinance.yahoo.com - December 18 at 12:03 PMmarketbeat.com - December 18 at 6:05 AMCyclacel Regains Compliance With Nasdaq Listing Rule Following Filing of Its Form 10-Q With the SECfinance.yahoo.com - November 30 at 12:09 PMCyclacel Pharmaceuticals GAAP EPS of -$0.49 misses by $0.13msn.com - November 14 at 3:55 PMCyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Q3 2023 Earnings Call Transcriptfinance.yahoo.com - November 14 at 3:55 PMCyclacel Pharmaceuticals Reports Third Quarter Financial Results and Provides Business Updatefinance.yahoo.com - November 13 at 6:37 PMmarketbeat.com - November 13 at 12:31 PMCyclacel Pharmaceuticals to Release Third Quarter 2023 Financial Resultsfinance.yahoo.com - November 7 at 9:40 AMCYCC Aug 2023 2.500 callfinance.yahoo.com - August 19 at 12:07 AMQ2 2023 Cyclacel Pharmaceuticals Inc Earnings Callfinance.yahoo.com - August 10 at 9:31 AMmarketbeat.com - July 24 at 9:30 AMCyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC) Q1 2023 Earnings Call Transcriptfinance.yahoo.com - May 16 at 2:11 PMQ1 2023 Cyclacel Pharmaceuticals Inc Earnings Callfinance.yahoo.com - May 12 at 9:07 AMRecap: Cyclacel Pharmaceuticals Q1 Earningsmsn.com - May 11 at 11:05 PMCyclacel Pharmaceuticals GAAP EPS of -$0.47 beats by $0.19msn.com - May 11 at 6:05 PMCyclacel Pharmaceuticals Reports First Quarter Financial Results and Provides Business Updatefinance.yahoo.com - May 11 at 6:05 PMCyclacel Pharmaceuticals receives $4.7M R&D tax creditseekingalpha.com - May 5 at 1:48 PMCyclacel Pharmaceuticals to Release First Quarter 2023 Financial Resultsfinance.yahoo.com - May 4 at 12:45 PMmarketbeat.com - March 7 at 1:24 PMQ4 2022 Cyclacel Pharmaceuticals Inc Earnings Callfinance.yahoo.com - March 7 at 9:50 AMCyclacel Pharmaceuticals to Participate in March Investor Conferencesfinance.yahoo.com - March 7 at 9:50 AMCyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2022 Financial Resultsfinance.yahoo.com - February 27 at 5:59 PMCYCC.O - | Stock Price & Latest News | Reutersreuters.com - January 22 at 1:45 PMCYCC.PH - | Stock Price & Latest News | Reutersreuters.com - January 20 at 6:43 PMCyclacel Pharmaceuticals Reviews 2022 Achievements and Announces Key Business Objectives for 2023finance.yahoo.com - January 5 at 10:40 AMmarketbeat.com - December 29 at 1:58 PMmarketbeat.com - December 29 at 1:41 PMCyclacel Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Business Updatefinance.yahoo.com - November 9 at 5:58 PMCyclacel Pharmaceuticals to Release Third Quarter 2022 Financial Resultsfinance.yahoo.com - November 3 at 11:58 AMCyclacel Hosting Research & Development Dayfinance.yahoo.com - October 24 at 11:44 AMCyclacel Pharmaceuticals to Present at the Ladenburg Thalmann 2022 Healthcare Conferencefinance.yahoo.com - September 21 at 10:02 AMmarketbeat.com - August 18 at 11:03 AMmarketbeat.com - August 16 at 10:58 AMCyclacel Pharmaceuticals, Inc. (CYCC) CEO Spiro Rombotis on Q2 2022 Results - Earnings Call Transcriptseekingalpha.com - August 10 at 10:56 PMCyclacel Pharmaceuticals Reports Second Quarter 2022 Financial Results and Provides Business Updatefinance.yahoo.com - August 10 at 5:55 PM Get Cyclacel Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CYCCP and its competitors with MarketBeat's FREE daily newsletter. Email Address Mysterious Gold Leverage Just Announced (Ad)World's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers. Find out what it is and see how you can get in with just a few dollars. CYCCP Media Mentions By Week CYCCP Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. CYCCP News Sentiment▼0.000.41▲Average Medical News Sentiment CYCCP News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. CYCCP Articles This Week▼20▲CYCCP Articles Average Week Get Cyclacel Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for CYCCP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Alpha Tau Medical News Today Artelo Biosciences News Today BriaCell Therapeutics News Today eFFECTOR Therapeutics News Today Fortress Biotech News Today GeoVax Labs News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:CYCCP) was last updated on 4/25/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingThese AI trades triggered this morning (545% return)Prosper Trading AcademyThe A.I. story nobody is telling you (Read ASAP)TradeSmithHe Is Giving Away BitcoinCrypto Swap Profitstop AI stock (it’s not MSFT, GOOGL, AMZN or AAPL)Traders AgencyThe only accurate crypto trading system I know …Weiss RatingsBitcoin Rockets To Record High But Buy THIS InsteadParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyclacel Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
